OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99 | +102.0% | 31,521 | +229.0% | 0.00% | – |
| Q2 2023 | $49 | -70.5% | 9,581 | -69.5% | 0.00% | – |
| Q1 2023 | $166 | +10.7% | 31,453 | -41.1% | 0.00% | – |
| Q4 2022 | $150 | -99.9% | 53,410 | +0.0% | 0.00% | – |
| Q3 2022 | $222,000 | +3.7% | 53,392 | +0.2% | 0.00% | – |
| Q2 2022 | $214,000 | -18.9% | 53,261 | -0.3% | 0.00% | – |
| Q1 2022 | $264,000 | -29.0% | 53,400 | +0.1% | 0.00% | – |
| Q4 2021 | $372,000 | -30.5% | 53,351 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $535,000 | -39.7% | 53,510 | -14.4% | 0.00% | 0.0% |
| Q2 2021 | $887,000 | -12.7% | 62,524 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $1,016,000 | -20.7% | 61,900 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,281,000 | +258.8% | 61,900 | +32.0% | 0.00% | – |
| Q3 2020 | $357,000 | -8.7% | 46,900 | 0.0% | 0.00% | – |
| Q2 2020 | $391,000 | +249.1% | 46,900 | +107.5% | 0.00% | – |
| Q1 2020 | $112,000 | +25.8% | 22,600 | 0.0% | 0.00% | – |
| Q4 2019 | $89,000 | +29.0% | 22,600 | 0.0% | 0.00% | – |
| Q3 2019 | $69,000 | -30.3% | 22,600 | 0.0% | 0.00% | – |
| Q2 2019 | $99,000 | +10.0% | 22,600 | 0.0% | 0.00% | – |
| Q1 2019 | $90,000 | 0.0% | 22,600 | 0.0% | 0.00% | – |
| Q4 2018 | $90,000 | -41.9% | 22,600 | 0.0% | 0.00% | – |
| Q3 2018 | $155,000 | +1.3% | 22,600 | 0.0% | 0.00% | – |
| Q2 2018 | $153,000 | +26.4% | 22,600 | +21.5% | 0.00% | – |
| Q1 2018 | $121,000 | +45.8% | 18,600 | 0.0% | 0.00% | – |
| Q4 2017 | $83,000 | -27.8% | 18,600 | 0.0% | 0.00% | – |
| Q3 2017 | $115,000 | -33.1% | 18,600 | 0.0% | 0.00% | – |
| Q2 2017 | $172,000 | +44.5% | 18,600 | +45.3% | 0.00% | – |
| Q1 2017 | $119,000 | +11.2% | 12,801 | +0.0% | 0.00% | – |
| Q4 2016 | $107,000 | +21.6% | 12,800 | 0.0% | 0.00% | – |
| Q3 2016 | $88,000 | +39.7% | 12,800 | 0.0% | 0.00% | – |
| Q2 2016 | $63,000 | -49.2% | 12,800 | 0.0% | 0.00% | – |
| Q1 2016 | $124,000 | +3.3% | 12,800 | 0.0% | 0.00% | – |
| Q4 2015 | $120,000 | -47.4% | 12,800 | -21.2% | 0.00% | – |
| Q3 2015 | $228,000 | +0.4% | 16,240 | +50.6% | 0.00% | – |
| Q2 2015 | $227,000 | – | 10,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |